NASDAQ
Olema Pharmaceuticals, Inc. (OLMA) has a free cash flow growth of -19.99% as of Friday, May 29, 2026. This represents a 29.32% decrease compared to its 12-month average of -15.45%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.